ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,582, issued on June 30, was assigned to Zoetis Services LLC (Parsippany, N.J.).
"Phosphodiesterase 3 (PDE3) inhibitors" was invented by Richard A. Ewin (Kalamazoo, Mich.), Michael P. Curtis (Kalamazoo, Mich.), Todd M. Maddux (Kalamazoo, Mich.) and Graham M. Kyne (Kalamazoo, Mich.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention describes novel PDE3 inhibitors for treating a cardiovascular disease including myxomatous mitral valve disease, congestive heart failure and/or asymptomatic heart failure in animals, particularly canines."
The patent was filed on March 7, 2024, under Application No. 18/598,312.
*For further information, includi...